University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies:
New Embolic Device for Tumor Treatment and Other Oncology Uses Given Nod by FDA to Start Pivotal Clinical Trial
Fluidx Medical Technology, Inc. announced that the FDA has granted Investigational Device Exemption (IDE) approval to initiate the GPX Embolic Device Pivotal Clinical Trial. The objective of this trial will be to evaluate the safety and effectiveness of the GPX Embolic Device.
